drugset / Trial / NCT06704334
The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury
Phase 4
Recruiting
50 enrolled
Wanbangde Pharmaceutical Group Co., LTD
Ganzhou City People's Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Timeline
- Start
- 2024-04-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ginkgo leaf dropping pill | Traditional medicine (herbal / TCM) | 315 mg | Oral |
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 0.2 mg | Intramuscular |